QLU
- Product code
- QLU
- Device name
- Anti-Factor Xa Activity Test System, Apixaban
- Device class
- Class 2
- 21 CFR
- 21 CFR 864.7295
- Medical specialty
- Hematology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 1 (direct download)
- 510(k) clearances (all years, FDA)
- 3 (all years; only the last 3 years are listed here)
FDA classification definition
A heparin and direct oral factor Xa inhibitor drug test system is intended for the detection of heparin and direct oral factor Xa inhibitors in human specimens collected from patients taking heparin or direct oral factor Xa inhibitors. This device is intended to aid in the management of therapy in conjunction with other clinical and laboratory findings.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K240315 | 2024-10-10 | Siemens Healthcare Diagnostics Product… | INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Stand… |
Official FDA classification page: QLU
Classification and pathway per current FDA publications. Data from openFDA (CC0).